Formulating an evidence-based treatment algorithm for neuropathic pain should be based on a number of factors, including a consistent outcome in randomized controlled studies of high quality ...

Although systematic reviews have outlined the current treatment options for neuropathic pain, subsequent trials have necessitated an update of the NUMBER NEEDED TO TREAT (NNT) values presented in ...

ITDD helps effectively manage chronic pain and spasticity in some patients but requires adherence to best practices and a ...

Researchers have found pregabalin highly effective in reducing neuropathic pain and itch in recessive dystrophic epidermolysis bullosa (RDEB), the most prevalent and debilitating form ...

With first-in-class potential, ricolinostat is currently positioned to enter a phase 2 clinical trial for diabetic neuropathic pain ... nerve function for the treatment of peripheral neuropathies ...

Neuropathic pain affects more than 20 million people in the U.S., and at least a quarter of these cases are puzzling for ...

Cannabidiol (CBD) holds great promise as a treatment ... pain, there’s a chance it may work for nerve pain. Neuropathy, or nerve dysfunction, doesn’t always result in nerve pain, or ...

Often seen as a safer alternative to opioids for the treatment of neuropathic pain, gabapentinoid use increased eightfold between 2012 and 2018, with one in seven Australians aged 80 and older ...

Neuropathic pain ... in transmitting sensitivity to pain. People with a genetic variant in opioid receptors may need higher doses of painkillers for the treatment of pain. Interestingly, one ...

Gary S. Jacob, CEO of OKYO Pharma. “This is a key step forward in our mission to provide relief for patients suffering from neuropathic corneal pain, a chronic condition for which no FDA-approved ...

Ketamir-2, a non-opioid, offers tremendous promise for patients seeking better solutions for neuropathic pain without the habit ... aimed at mental health treatment. These grants could help ...